• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 86 of 100
US-CRIME-JUSTICE-SHKRELI
Health
Turing Replaces Martin Shkreli with Interim CEO
By Laura LorenzettiDecember 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership
Martin Shkreli’s 15 Minutes Are Up
By Geoff ColvinDecember 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Health
How Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest
By ReutersDecember 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
Health
Europe’s Pharma Sector Is Finishing 2015 With a Deal Flurry
By Geoffrey SmithDecember 18, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance
The Year’s Best VC Deal Was for a Company You’ve Never Heard Of
By Dan PrimackDecember 17, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
AstraZeneca Wants a Stake in This Biotech Firm for a Cancer Cure
By ReutersDecember 17, 2015
Views Of A CVS Caremark Corp. Store Ahead Of Earns
Retail
CVS Slams Walgreens-Valeant Distribution Deal
By Phil WahbaDecember 16, 2015
MSMB Capital Management CIO Martin Shkreli
Leadership
Yet Another Reason to Hate Martin Shkreli
By Daniel RobertsDecember 16, 2015
468673318
Health
Here’s How Your Health Care Is Going to Change in 2016
By Laura LorenzettiDecember 16, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Congressman Calls Out Valeant’s ‘Lack of Transparency’
By Laura LorenzettiDecember 16, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Retail
Walgreens Comes to Valeant’s Help
By Phil WahbaDecember 15, 2015
Cindy Whitehead, chief executive officer of Sprout Pharmaceuticals Inc., speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, Aug. 19, 2015. Whitehead discussed Addyi, the company's pill for low libido in women that won approval from the U.S. Food and Drug Administration yesterday. Photographer: Chris Goodney/Bloomberg *** Local Caption *** Cindy Whitehead
MPW
CEO Behind ‘Female Viagra’ Leaves Company After Valeant Purchase
By Laura LorenzettiDecember 10, 2015
This Is What Happens When Cheap Drugs Get Wildly Expensive
Health
This Is What Happens When Cheap Drugs Get Wildly Expensive
By Laura LorenzettiDecember 9, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Infamous Pharma CEO Martin Shkreli Paid $2 Million for a Wu-Tang Album
By Daniel RobertsDecember 9, 2015
Yuan Direction and Drug Price Hearing–5 Things to Know Today
Leadership
Yuan Direction and Drug Price Hearing–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithDecember 9, 2015
1...
  • 84
  • 85
  • 86
  • 87
  • 88
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.